A distinctive feature of the SARS-CoV-2 spike protein is its ability to efficiently fuse cells, thus
producing syncytia found in COVID-19 patients. This commentary proposes how this ability …

The coagulopathy of COVID-19 is characterised by significantly elevated D Dimer and
fibrinogen, mild thrombocytopenia and a mildly prolonged PT/APTT. A high incidence of …

Venous thromboembolism, in particular, pulmonary embolism (PE), is a significant
contributor to the morbidity and mortality associated with COVID-19. In this study, we utilized …

Abstract The coronavirus disease 2019 (COVID-19) caused by the severe acute respiratory
syndrome coronavirus-2 has affected the health of people across the globe. Cardiovascular …

Clinical knowledge about SARS-CoV-2 infection mechanisms and COVID-19
pathophysiology have enormously increased during the pandemic. Nevertheless, because …

Introduction: E-selectin is a recognized marker of endothelial activation; however, its place in
Coronavirus Disease 2019 (COVID-19) has not been fully explored. Aims of the study are to …

The biggest challenge in the COVID-19 pandemic besides the spread of the SARS-CoV-2
virus is to reduce mortality rates. As the number of cases continues to rise and new variants …

The increased plasma levels of von Willebrand factor (VWF) in patients with COVID-19 was
reported in many studies, and its correlation with disease severity and mortality suggest its …

Severe coronavirus disease 2019 causes multi-organ dysfunction with significant morbidity
and mortality. Mounting evidence implicates maladaptive over-activation of innate immune …

Several studies have discovered a relationship between specific blood types, genetic
variations of the ABO gene, and coronavirus disease 2019 (COVID‐19). Therefore, the aim …